Teknova AI lets developers configure custom reagents in minutes
Teknova (Nasdaq: TKNO) has launched Build-Tek™, an AI-powered configurator that allows therapeutic and diagnostic developers to design complex custom reagents and submit quote requests in minutes. This system guides users through various specifications, significantly reducing the time for quote generation from weeks to two …